MRC2 and neoplasm: Impairment of a distinct CAFs population limits tumor growth and metastasis [38], where genetic deletion of the Endo180 (MRC2, bSE = 4.3) receptor, predominantly expressed by a population of matrix-remodeling CAFs, profoundly limits tumor growth and metastasis.